Home Site Essentials Site Map prev next Site Map Strategic Report Our Business Highlights Introduction Group at a Glance Chairman's Statement Reasons to Invest Business Model Strategy DVP EU Strengths and Capabilities DVP US Strengths and Capabilities International Footprint Key Products and Specialisations Manufacturing Strengths and Capabilities Product Development Product Pipeline Our Performance Chief Executive Officer's Q&A Operating Review Overview Product Development and Regulatory Affairs European Performance US Performance Key Performance Indicators ("KPIs") Financial Review Risk and Risk Management Our Governance Board of Directors Letter from the Chairman on Governance Corporate Governance Directors' Report: Corporate Governance Leadership Effectiveness Accountability Relations with Shareholders Letter from the Audit Committee Chairman Audit Committee Report Letter from the Remuneration Committee Chairman Directors' Remuneration Report Remuneration Policy and Practice Corporate Responsibility, Social, Ethical and Environmental Responsibilities Dechra Values Directors' Report: Other Disclosures Statement of Directors' Responsibilities Our Financials Independent Auditor's Report to the Members of Dechra Pharmaceuticals PLC Consolidated Income Statement Consolidated Statement of Comprehensive Income Consolidated Statement of Financial Position Consolidated Statement of Changes in Shareholders' Equity Consolidated Statement of Cash Flows Notes to the Consolidated Financial Statements Company Balance Sheet Reconciliation of Movements in Shareholders' Funds Notes to the Company Financial Statements Financial History Shareholder Information Glossary Shareholder Information Advisers